Summary
Diastereomeric para-substituted dichloro-(1,2-diphenylethylenediamine)platinum(II) complexes were synthesized and tested for their antitumor activity on the human MDA-MB 231 breast cancer cell line and the P 388 leukemia of the mouse. An interaction with the DNA was demonstrated by UV difference spectroscopy. The D,L configurated, 4-fluoro-substituted complex was the most active.
Similar content being viewed by others
References
Dawe CJ, Potter M (1957) Lymphocytic leukemia P 388 of the DBA/2 mouse. Am J Pathol 33:603
Foglia TA, Swern DJ (1966) Pseudo-halogens VII Scope and mechanism of addition ofN,N-dichloro-urethane to monoolefinic compounds. J Org Chem 31:3625–3631
Foglia TA, Swern DJ (1967) Pseudo-halogens. VIII. New synthesis of aziridines and oxazolidones. J Org Chem 32:75–78
Geran RT, Greenberg NH, Macdonald MM, Schumacher AH, Abbott B (1972) Protocols for screening chemical agents and natural products against animal tumors and other biological systems. J Cancer Chemother Rep 3:9
Gullotti M, Pasini A, Ugo R, Filippeschi S, Marmonti L, Spreafico F (1984) Enantiomeric cisplatin analogues; an investigation on their activity towards tumors in mice. Inorg Chim Acta 91:223–227
Hansch C, Venger BH, Panthanaichal A (1980) Mutagenicity of substituted (o-phenylenediamine)platinum dichloride in the Ames test. A quantitative structure-activity analysis. J Med Chem 23:459–461
Inagaki K, Kidani Y (1980) Ultraviolet difference spectral study of the interaction of DNA with platinum complexes. Inorg Chim Acta 46:35–39
Inagaki K, Ninomiya Ch, Kidani Y (1986) Interaction of DNA with antitumor active platinum complexes. Platinum complex involving meso diamine ligand gave two Pt-d(GpG)adducts. Chem Lett 1986:233–236
Karl J, Gust R, Spruß Th, Schneider MR, Schönenberger H, Engel J, Wrobel KH, Lux F, Trebert-Haeberlin S (1988) Ring substituted [1,2-bis(4-hydroxy phenyl)ethylenediamine] dichloroplatinum(II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. J Med Chem 31:72–83
Kidani Y, Asano Y, Noji M (1979) Synthesis of platinum(II) complexes of 4-substituted o-phenylendiamine derivatives and determination of their antitumor activity. Chem Pharm Bull 27:2577–2581
Lippman M, Monaco ME, Bolan C (1977) Effects of estrone, estradiol and estriol on hormone responsive human breast cancer in long-term tissue culture. Cancer Res 37:1901–1907
Mylonas S, Valavanidis A, Voukouvalidis V, Polyssiou M (1981) Platinum(II) and palladium(II) complexes with amino acid derivatives. Synthesis, interpretation of IR and1H-NMR spectra and conformational implications. Inorg Chem Acta 55:125–128
Noji M, Gohchi Y, Kidani Y (1984) Preparation of antitumor platinum(II) complexes of 1,2-diphenylethylenediamine isomers and their interaction with DNA and its purine moieties. Chem Biol Interact 51:37–48
Schönenberger R, Sunkel C, Schönenberger H (1975) Konfigurative Zuordnung diastereomererN,N′-Dialkyl-α,α′-diphenyläthylen-diamine durch Kernresonanzspektroskopie. Arzneimittel Forsch 22:1952–1955
Seeber S, Osieka R, Schmidt CG, Achterrath W, Crooke ST (1982) In vivo resistance towards anthracyclines, etoposide and cisdiammineplatinum(II). Cancer Res 42:4719–4725
Vögtle V, Goldschmitt E (1976) Die Diaza-Cope-Umlagerung. Chem Ber 109:1–10
Wappes B, Jennerwein M, von Angerer E, Engel J, Schönenberger H, Brunner H, Schmidt M, Berger M, Schmähl D, Seeber S (1984a) The tumor inhibiting effect of isomeric dichloro(diphenylethylenediamine)platinum(II)-complexes. J Cancer Res Clin Oncol 107:15–20
Wappes B, Jennerwein M, von Angerer E, Schönenberger H, Engel J, Berger M, Wrobel K-H (1984b) Dichloro 1,2-bis(4-hydroxyphenyl)ethylenediamine platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma. J Med Chem 27:1280–1286
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jennerwein, M., Wappes, B., Gust, R. et al. Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes. J Cancer Res Clin Oncol 114, 347–358 (1988). https://doi.org/10.1007/BF02128177
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02128177